(44 20) 74 18 84 00 fax (44 20) 74 18 84 16 e mail mail@ emea eu int http // www emea eu int ©emea 2006 reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the emea is acknowledged učinkovitost zdravila baraclude pri kroničnem hepatitisu b je bila primerjana s tisto ki jo ima zdravilo lamivudin v treh glavnih kliničnih študijah